Benfotiamine Pharmaceutical Grade from Japan
Benfotiamine is a lipid-soluble thiamine derivative with enhanced bioavailability, used in neuropathy treatments. Falls under HTS 2936.22.00.00 as a synthetic vitamin B1 derivative for pharmaceutical applications. Its S-benzoyl structure improves absorption over standard thiamine forms.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Submit IND documentation if importing for clinical trials to meet FDA requirements
• Stability data showing 24-month shelf life required for bulk pharmaceutical imports
• Avoid 'dietary supplement' labeling to prevent dual FDA/FSMA oversight